Captrust Financial Advisors Has $3.44 Million Stock Holdings in STERIS plc (NYSE:STE)

Captrust Financial Advisors increased its stake in shares of STERIS plc (NYSE:STE) by 65.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,743 shares of the medical equipment provider’s stock after buying an additional 6,638 shares during the period. Captrust Financial Advisors’ holdings in STERIS were worth $3,442,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cary Street Partners Financial LLC acquired a new position in shares of STERIS during the fourth quarter worth approximately $80,000. Balyasny Asset Management L.P. acquired a new position in STERIS during the 4th quarter worth $23,800,000. Bellevue Group AG boosted its position in STERIS by 20.4% in the 4th quarter. Bellevue Group AG now owns 109,887 shares of the medical equipment provider’s stock valued at $22,588,000 after buying an additional 18,605 shares during the last quarter. Benjamin Edwards Inc. increased its stake in shares of STERIS by 1.0% in the 4th quarter. Benjamin Edwards Inc. now owns 114,861 shares of the medical equipment provider’s stock valued at $23,614,000 after buying an additional 1,189 shares during the period. Finally, BNP Paribas Financial Markets raised its position in shares of STERIS by 44.8% during the fourth quarter. BNP Paribas Financial Markets now owns 163,280 shares of the medical equipment provider’s stock worth $33,564,000 after acquiring an additional 50,514 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Up 0.3 %

Shares of NYSE:STE opened at $226.54 on Friday. The company has a 50 day moving average price of $223.40 and a two-hundred day moving average price of $218.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The company has a market capitalization of $22.26 billion, a PE ratio of 48.10 and a beta of 0.96. STERIS plc has a 52 week low of $200.98 and a 52 week high of $248.24.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be given a $0.57 dividend. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. STERIS’s dividend payout ratio is presently 48.41%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on STE shares. Stephens upgraded STERIS to a “strong-buy” rating in a report on Thursday, May 1st. JMP Securities reiterated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, April 10th. Piper Sandler raised their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Finally, Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Monday, April 7th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, STERIS currently has an average rating of “Buy” and a consensus target price of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.